Gagnon Robert E. bought IRD
September 2, 2025 · Form 4 insider transaction
Gagnon Robert E. bought 250,000 shares of Opus Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 9 days after the transaction.
Direction
Acquired (buy-side)
Shares
250,000
Price
$0.00
Total value
N/A
InsiderGagnon Robert E.
RoleOfficer
CompanyOpus Genetics, Inc. (IRD)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateSeptember 2, 2025
Filing dateSeptember 11, 2025
Shares owned after250,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.